Mandate

Investor Growth Capital investing in SciBase AB

August 15, 2006

Investor Growth Capital, SEB and CapMan are investing SEK 100 million in the medical technology company SciBase AB. The investment means that Investor Growth Capital, together with the former owners SEB Företagsinvest and CapMan will control 80% of the Swedish medical technology company.

Vinge acted as advisor to Investor Growth Capital and representatives from Vinge included Johan Winnerblad and Johan Larsson.

Vinge hones its offering within capital requirements and risk management in the financial services sector

In order to further strenghthen its service offering within the Banking & Finance and Regulatory practice area, Vinge has formed a team within the capital requirements and risk management in the financial services sector. Torbjörn Jacobsson, whose background includes, among other things, head of risk in the banking sector, has been recruited to lead the group as a senior specialist in relation to issues concerning financial risks and capital requirements.
November 30, 2021

Emelie Svensäter Jerntorp appointed as new partner

Commencing 1 January 2022, Emelie Svensäter Jerntorp will become a partner at Vinge’s Skåne office.
November 19, 2021

Sweden proposes a new law on investment screening which will have significant implications for transactions

Contrary to the situation in many other countries, there are currently only limited possibilities to regulate or prevent foreign direct investments in Sweden that could entail risks to Swedish security interests. Existing regulatory frameworks, such as the Protective Security Act (Sw. Säkerhetsskyddslagen), are limited to certain areas, to certain activities and to specific situations. The final report of the Inquiry of foreign direct investments (Sw. Granskning av utländska direktinvesteringar), published on 1 November 2021, puts forward a proposal for new legislation to address this gap.
November 04, 2021